BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34743190)

  • 1. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.
    Tanabe M; Hosokawa K; Nguyen MAT; Nakagawa N; Maruyama K; Tsuji N; Urushihara R; Espinoza L; Elbadry MI; Mohiuddin M; Katagiri T; Ono M; Fujiwara H; Chonabayashi K; Yoshida Y; Yamazaki H; Hirao A; Nakao S
    Leukemia; 2022 Mar; 36(3):847-855. PubMed ID: 34743190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
    Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
    Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.
    Murray LJ; Bruno E; Uchida N; Hoffman R; Nayar R; Yeo EL; Schuh AC; Sutherland DR
    Exp Hematol; 1999 Aug; 27(8):1282-94. PubMed ID: 10428505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
    Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
    Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.
    Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M
    Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
    Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
    J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses.
    Li C; Hancock MA; Sehgal P; Zhou S; Reinhardt DP; Philip A
    Biochem J; 2016 Mar; 473(5):537-47. PubMed ID: 26621871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative Effect of Erythropoietin and TGF-β Inhibition on Erythroid Development in Human Pluripotent Stem Cells.
    Xie Y; Bai H; Liu Y; Hoyle DL; Cheng T; Wang ZZ
    J Cell Biochem; 2015 Dec; 116(12):2735-43. PubMed ID: 26012423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
    Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
    Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors.
    Bizet AA; Liu K; Tran-Khanh N; Saksena A; Vorstenbosch J; Finnson KW; Buschmann MD; Philip A
    Biochim Biophys Acta; 2011 May; 1813(5):742-53. PubMed ID: 21295082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
    Zhou S; da Silva SD; Siegel PM; Philip A
    Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis.
    Liu XX; Feng AP; He YM; Li Y; Wu Y; Lian X; Hu F; Li JW; Tu YT; Chen SJ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):132-136. PubMed ID: 26838754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
    Man XY; Finnson KW; Baron M; Philip A
    Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling.
    Naoi H; Suzuki Y; Miyagi A; Horiguchi R; Aono Y; Inoue Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Mii S; Ichihara M; Takahashi M; Suda T
    J Immunol; 2024 Apr; 212(7):1221-1231. PubMed ID: 38334455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
    Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M
    Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes.
    Finnson KW; Tam BY; Liu K; Marcoux A; Lepage P; Roy S; Bizet AA; Philip A
    FASEB J; 2006 Jul; 20(9):1525-7. PubMed ID: 16754747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEIS1 regulates early erythroid and megakaryocytic cell fate.
    Zeddies S; Jansen SB; di Summa F; Geerts D; Zwaginga JJ; van der Schoot CE; von Lindern M; Thijssen-Timmer DC
    Haematologica; 2014 Oct; 99(10):1555-64. PubMed ID: 25107888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling.
    Mori N; Esaki N; Shimoyama Y; Shiraki Y; Asai N; Sakai T; Nishida Y; Takahashi M; Enomoto A; Mii S
    Pathol Res Pract; 2023 May; 245():154443. PubMed ID: 37030166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
    Yokoyama M; Ichinoe M; Okina S; Sakurai Y; Nakada N; Yanagisawa N; Jiang SX; Numata Y; Umezawa A; Miyazaki K; Higashihara M; Murakumo Y
    Int J Hematol; 2017 May; 105(5):614-622. PubMed ID: 28032275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.